Literature DB >> 32672531

Effect of COVID-19 on Tuberculosis Notification, South Korea.

Nakwon Kwak, Seung-Sik Hwang, Jae-Joon Yim.   

Abstract

After South Korea raised its infectious disease alert to the highest level in response to coronavirus disease emergence, tuberculosis notification during the first 18 weeks of 2020 decreased significantly from the same period for each year during 2015-2019. Adequate measures to diagnose, control, and prevent tuberculosis need to be maintained.

Entities:  

Keywords:  2019 novel coronavirus disease; COVID-19; SARS-CoV-2; South Korea; bacteria; coronavirus disease; respiratory diseases; severe acute respiratory syndrome coronavirus 2; tuberculosis; tuberculosis and other mycobacteria; viruses; zoonoses

Mesh:

Year:  2020        PMID: 32672531      PMCID: PMC7510739          DOI: 10.3201/eid2610.202782

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


The first case of coronavirus disease (COVID-19) in South Korea was identified on January 20, 2020, and an outbreak from a church hastened widespread transmission throughout the country (). On February 23, the government of South Korea raised the country’s infectious disease alert to the highest level and initiated vigorous infection control measures: establishing widespread diagnostic capacity, initiating local contact tracing, mandating physical distancing, and redesigning triage and treatment systems (). While this alert level remains in effect, such measures could negatively affect other communicable diseases, such as tuberculosis (TB) (). To investigate the effect of COVID-19 on TB diagnoses, we traced the number of notified TB cases in South Korea before and after the COVID-19 outbreak started and compared them with previous years, during which the burden of TB has been at an intermediate level. We gathered the weekly number of newly notified TB cases for 2015–2020 from the Public Health Weekly Report released by the Korea Centers for Disease Control and Prevention. In South Korea, physicians and healthcare workers are required to report confirmed or clinically diagnosed TB to health authorities within 24 hours, irrespective of any previous history of TB treatment (). The Public Health Weekly Report publishes the number of notified TB cases by province every week (). In addition, the number of confirmed COVID-19 cases is posted daily on the Korea Centers for Disease Control and Prevention website (). We calculated the mean number of weekly TB notifications from the 1st through the 18th week of each year from 2015 through 2019. We also collected the weekly number of notified TB cases during the same period in 2020. We compared the number of cases before and after the highest alert level was declared (weeks 1–8 [before the COVID-19 outbreak began] and weeks 9–18 [after the COVID-19 outbreak began]). We estimated the change in the number of notified TB cases in 2020 after the COVID-19 outbreak started by comparing the latest numbers with those from previous years using a Bayesian structural time-series model (). We used R statistical software version 4.0.2 (https://www.r-project.org) for all statistical analyses. During 2015–2019, a mean number of 594 TB cases were notified weekly during weeks 1–8 and a mean number of 655 TB cases were notified weekly during weeks 9–18. In 2020, a mean of 498 TB cases were notified each week during weeks 1–8; the mean number of notifications during weeks 9–18 decreased to 390 cases/week. After COVID-19 began, TB notification decreased by 24% (121 cases/week; p<0.01 from the predicted number in 2020 based on a Bayesian structural time-series model) (Figure). In Daegu and Gyeongbuk Provinces, the epicenter of COVID-19 in South Korea, TB notification decreased by 23% (14 cases/week; p = 0.003). In other provinces, patterns were similar; TB notification decreased by 25% (112 cases/week; p = 0.001) after COVID-19 began (Table).
Figure

Mean weekly number of TB and COVID-19 case notifications in 2020 compared with the previous 5-year period, South Korea. Triangles indicate TB cases during 2015–2019; squares indicate TB cases during 2020; circles indicate COVID-19 cases during 2020. COVID-19, coronavirus disease; TB, tuberculosis.

Table

Weekly mean number of TB case notifications in 2020 compared with the previous 5-year period, South Korea

Location, calendar week†Mean no. TB cases
Difference between actual and predicted cases after COVID-19 in 2020 (95% CI)
2015–20192020
All provinces−121 (−165 to −86)
1–8594498
9–18
655
390

Daegu and Gyeongbuk Provinces−14 (−24 to −3)
1–87057
9–18
77
46

Other provinces−112 (−153 to −79)
1–8524441
9–18576344

*COVID-19, coronavirus disease; TB, tuberculosis.
†Weeks 1–8, before COVID-19 outbreak; weeks 9–18, after start of COVID-19 outbreak.

Mean weekly number of TB and COVID-19 case notifications in 2020 compared with the previous 5-year period, South Korea. Triangles indicate TB cases during 2015–2019; squares indicate TB cases during 2020; circles indicate COVID-19 cases during 2020. COVID-19, coronavirus disease; TB, tuberculosis. *COVID-19, coronavirus disease; TB, tuberculosis.
†Weeks 1–8, before COVID-19 outbreak; weeks 9–18, after start of COVID-19 outbreak. Our analysis demonstrated that the COVID-19 pandemic led to a decrease in TB notification in South Korea and that this reduction was not confined to the Daegu and Gyeongbuk Province areas. Although the number of TB cases in South Korea has decreased steadily since 2010 (), the 24% decrease in TB notification after COVID-19 began is larger than that predicted by our time-series model. The reduced number of TB notifications could reflect decreased transmission associated with physical distancing and the increased use of face masks. Recent analysis proposed that physical distancing could decrease transmission of TB by 10% in high TB burden countries (). However, the 24% reduction in South Korea, which has an intermediate burden of TB, suggests the additional contribution of other factors. First, during the COVID-19 outbreak, interventions such as TB contact investigation and preventive therapy may have been deprioritized and delayed (). Second, patients with newly developed respiratory symptoms could not visit chest clinics easily because those patients were redirected to COVID-19 screening clinics to prevent in-hospital transmission (). The negative effect of the COVID-19 outbreak on TB has not been confined to diagnosis. In South Korea, outpatient clinics and emergency departments have been temporarily closed after patients visiting the facility have been identified as having COVID-19 (). Negative-pressure units also have been prioritized for COVID-19 patients (). Overall healthcare use worsens during outbreaks of communicable diseases, as demonstrated by the 10%–23% decrease in emergency department visits, even for life-threatening conditions, after COVID-19 began, as reported in the United States (). In summary, we found that TB notifications decreased significantly with the surge of COVID-19 in South Korea. Adequate measures to diagnose, control, and prevent TB, a much older and more burdensome infectious killer than COVID-19, need to be maintained during this pandemic.
  4 in total

1.  National Response to COVID-19 in the Republic of Korea and Lessons Learned for Other Countries.

Authors:  Juhwan Oh; Jong-Koo Lee; Dan Schwarz; Hannah L Ratcliffe; Jeffrey F Markuns; Lisa R Hirschhorn
Journal:  Health Syst Reform       Date:  2020-01-01

2.  Achievements in and Challenges of Tuberculosis Control in South Korea.

Authors:  Ji Han Kim; Jae-Joon Yim
Journal:  Emerg Infect Dis       Date:  2015-11       Impact factor: 6.883

3.  Potential Indirect Effects of the COVID-19 Pandemic on Use of Emergency Departments for Acute Life-Threatening Conditions - United States, January-May 2020.

Authors:  Samantha J Lange; Matthew D Ritchey; Alyson B Goodman; Taylor Dias; Evelyn Twentyman; Jennifer Fuld; Laura A Schieve; Giuseppina Imperatore; Stephen R Benoit; Aaron Kite-Powell; Zachary Stein; Georgina Peacock; Nicole F Dowling; Peter A Briss; Karen Hacker; Adi V Gundlapalli; Quanhe Yang
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-06-26       Impact factor: 17.586

4.  A Lesson from Temporary Closing of a Single University-affiliated Hospital owing to In-Hospital Transmission of Coronavirus Disease 2019.

Authors:  Heayon Lee; Jung Won Heo; Sei Won Kim; Jehoon Lee; Jung Hyun Choi
Journal:  J Korean Med Sci       Date:  2020-04-06       Impact factor: 2.153

  4 in total
  17 in total

1.  Discovery of substituted benzyloxy-benzylamine inhibitors of acetyltransferase Eis and their anti-mycobacterial activity.

Authors:  Allan H Pang; Keith D Green; Nishad Thamban Chandrika; Atefeh Garzan; Ankita Punetha; Selina Y L Holbrook; Melisa J Willby; James E Posey; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  Eur J Med Chem       Date:  2022-08-18       Impact factor: 7.088

2.  The secondary outcome of public health measures amidst the COVID-19 pandemic in the spread of other respiratory infectious diseases in Thailand.

Authors:  Nji T Ndeh; Yacob T Tesfaldet; Jariya Budnard; Pavadee Chuaicharoen
Journal:  Travel Med Infect Dis       Date:  2022-05-04       Impact factor: 20.441

3.  Impact of COVID-19 Pandemic on the National PPM Tuberculosis Control Project in Korea: the Korean PPM Monitoring Database between July 2019 and June 2020.

Authors:  Jinsoo Min; Hyung Woo Kim; Hyeon Kyoung Koo; Yousang Ko; Jee Youn Oh; Jaetae Kim; Jiyeon Yang; Yunhyung Kwon; Young Joon Park; Ji Young Kang; Sung Soon Lee; Jae Seuk Park; Ju Sang Kim
Journal:  J Korean Med Sci       Date:  2020-11-09       Impact factor: 2.153

4.  TB and COVID - Public and private health sectors adapt to a new reality.

Authors:  Joel Shyam Klinton; Charity Oga-Omenka; Petra Heitkamp
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2020-10-29

5.  Tuberculosis - United States, 2020.

Authors:  Molly Deutsch-Feldman; Robert H Pratt; Sandy F Price; Clarisse A Tsang; Julie L Self
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-03-26       Impact factor: 17.586

6.  The impact of the COVID-19 pandemic and associated suppression measures on the burden of tuberculosis in India.

Authors:  Matthew Arentz; Jianing Ma; Peng Zheng; Theo Vos; Christopher J L Murray; Hmwe H Kyu
Journal:  BMC Infect Dis       Date:  2022-01-27       Impact factor: 3.090

7.  Real-Time Impact of COVID-19 on Clinical Care and Treatment of Patients with Tuberculosis: A Multicenter Cross-Sectional Study in Addis Ababa, Ethiopia.

Authors:  Dagmawi Chilot; Yimtubezinash Woldeamanuel; Tsegahun Manyazewal
Journal:  Ann Glob Health       Date:  2021-11-15       Impact factor: 2.462

8.  Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China.

Authors:  Xiaolin Wang; Wencong He; Juan Lei; Guangtian Liu; Fei Huang; Yanlin Zhao
Journal:  Front Public Health       Date:  2021-05-21

9.  Increased Healthcare Delays in Tuberculosis Patients During the First Wave of COVID-19 Pandemic in Korea: A Nationwide Cross-Sectional Study.

Authors:  Jinsoo Min; Yousang Ko; Hyung Woo Kim; Hyeon-Kyoung Koo; Jee Youn Oh; Yun-Jeong Jeong; Hyeon Hui Kang; Kwang Joo Park; Yong Il Hwang; Jin Woo Kim; Joong Hyun Ahn; Yangjin Jegal; Ji Young Kang; Sung-Soon Lee; Jae Seuk Park; Ju Sang Kim
Journal:  J Korean Med Sci       Date:  2022-01-17       Impact factor: 2.153

10.  It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV.

Authors:  Alexander W Kay; Tara E Ness; Leonardo Martinez; Anna M Mandalakas
Journal:  Am J Trop Med Hyg       Date:  2020-10       Impact factor: 3.707

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.